Concepedia

Ken Yamada

KY

6

Publications

622

Citations

6

H-Index

2002

Active since

Affiliations

Novartis (United States)(Current)

The University of Tokyo

Novartis (Japan)

Ken Yamada is an author at Novartis (United States) specializing in pharmacology, medicinal chemistry, and organic chemistry.

Top concepts

PharmacologyMedicineEngineeringNatural SciencesOrganic ChemistryMedicinal ChemistryChemistryPhysiologyBiochemistryDrug Discovery

Publications per year

2002–2017

6

Publications

6

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 162 citations · Full text

Molecular Physiology, Kidney Research, Medicine +8

A Mild Copper-mediated Intramolecular Amination of Aryl Halides

Ken Yamada, Tetsuji Kubo, Hidetoshi Tokuyama et al. · Synlett · 2002 · 146 citations

Aryl Halides, Chemical Engineering, Cross-coupling Reaction +10

Total Synthesis of the Duocarmycins

Ken Yamada, Toshiki Kurokawa, Hidetoshi Tokuyama et al. · Journal of the American Chemical Society · 2003 · 133 citations

Medicinal Chemistry, Selective Lithiation, Bioorganic Chemistry +12

A mild inter- and intramolecular amination of aryl halides with a combination of CuI and CsOAc

Tetsuji Kubo, Chiharu Katoh, Ken Yamada et al. · Tetrahedron · 2008 · 100 citations

Aryl Halides, Novel Organocatalysts, Cross-coupling Reaction +7

Discovery and Characterization of Allosteric WNK Kinase Inhibitors

Ken Yamada, Ji-Hu Zhang, Xiaoling Xie et al. · ACS Chemical Biology · 2016 · 44 citations · Full text

Molecular Docking, Medicinal Chemistry, Drug Target +12

Rows per page

1–5 of 6